Blood–Brain Barrier and Neuronal Model Systems for Studying CoQ10 Metabolism

Mantle, D, Cufflin, N, Dewsbury, M and Hargreaves, IP orcid iconORCID: 0000-0002-2760-5603 (2025) Blood–Brain Barrier and Neuronal Model Systems for Studying CoQ10 Metabolism. Antioxidants, 15 (1).

[thumbnail of Blood–Brain Barrier and Neuronal Model Systems for Studying CoQ10 Metabolism.pdf]
Preview
Text
Blood–Brain Barrier and Neuronal Model Systems for Studying CoQ10 Metabolism.pdf - Published Version
Available under License Creative Commons Attribution.

Download (669kB) | Preview

Abstract

The disparity in outcomes between preclinical and clinical studies supplementing coenzyme Q10 (CoQ10) in neurological disorders may be a reflection of the differences in the ability of supplemental CoQ10 to access the blood–brain barrier (BBB) in rodents and in humans, which is, in turn, a consequence of contrasting structures of the BBB. The applicability of in vivo animal models to study access of CoQ10 across the BBB and subsequent neuronal metabolism has, therefore, been questioned, and there is an argument, perhaps surprisingly, that in vitro model systems (particularly 3D cellular systems) may be more appropriate. In this article, we have, therefore, reviewed the role of model systems to study the access of CoQ10 across the BBB, as well as the role of such systems in studying the role of CoQ10 in aspects of neuronal metabolism, such as mitochondrial and lysosomal function. In addition, the use of such model systems to study the interactions of CoQ10 with vitamin E and selenium has been reviewed. Finally, the practical application of a neuronal model system to investigate the effect of CoQ10 supplementation on CoQ10 status and mitochondrial metabolism in a CoQ10 deficiency state has been described.
Keywords: coenzyme Q10; vitamin E; selenium; blood–brain barrier; 2D and 3D model systems; intranasal; STARD7

Item Type: Article
Uncontrolled Keywords: 3101 Biochemistry and cell biology; 3205 Medical biochemistry and metabolomics; 3214 Pharmacology and pharmaceutical sciences
Subjects: R Medicine > R Medicine (General)
Divisions: Biological and Environmental Sciences (from Sep 19)
Publisher: MDPI AG
Date of acceptance: 25 December 2025
Date of first compliant Open Access: 6 January 2026
Date Deposited: 06 Jan 2026 14:53
Last Modified: 06 Jan 2026 14:53
DOI or ID number: 10.3390/antiox15010041
URI: https://researchonline.ljmu.ac.uk/id/eprint/27808
View Item View Item